Third Party Performance Data

To confirm reproducibility and robustness, Trenchant collaborated with Invetech, a global leader in advanced therapy manufacturing and product development, to perform testing using the identical Trenchant prototype platform, cassettes, and protocols.

Study Design

Invetech conducted three process runs with the assistance of Trenchant at Invetech laboratories using fresh human apheresis sourced from healthy donors. All critical unit operations—washing, selection, activation, and transduction were evaluated under controlled laboratory conditions.

Third Party Performance Results

Apheresis Wash Recovery

94.3%

Mean T-cell recovery

Single-step T-cell Selection & Activation Recovery

96.4%

Mean T-cell recovery

98.4%

Mean T-cell purity

Lentiviral Transduction Efficiency

73.6%

Mean GFP-positive cells